- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/39 - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Patent holdings for IPC class A61K 38/39
Total number of patents in this class: 1693
10-year publication summary
115
|
111
|
138
|
133
|
139
|
161
|
138
|
140
|
154
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4886 |
41 |
Gelita AG | 223 |
27 |
Osiris Therapeutics, Inc. | 99 |
20 |
The Johns Hopkins University | 5519 |
19 |
FUJIFILM Corporation | 28467 |
15 |
Warsaw Orthopedic, Inc. | 3169 |
15 |
Allergan Pharmaceuticals International Limited | 242 |
15 |
Janssen Biotech, Inc. | 1458 |
14 |
Geltor, Inc. | 56 |
14 |
Lonza Greenwood LLC | 103 |
14 |
Société des Produits Nestlé S.A. | 9224 |
12 |
The Regents of the University of California | 19479 |
12 |
CorMatrix Cardiovascular, Inc. | 180 |
12 |
Sustain Holdings, LLC | 16 |
12 |
The Board of Trustees of the Leland Stanford Junior University | 6226 |
11 |
Ethicon, Inc. | 1244 |
11 |
University of Utah Research Foundation | 1774 |
11 |
Wake Forest University Health Sciences | 714 |
11 |
Mayo Foundation for Medical Education and Research | 3100 |
10 |
Immunoforge Co., Ltd. | 29 |
10 |
Other owners | 1387 |